Canaccord Genuity Reiterates Buy on Staar Surgical, Maintains $77 Price Target
Portfolio Pulse from Benzinga Newsdesk
Canaccord Genuity analyst William Plovanic has reiterated a Buy rating on Staar Surgical (NASDAQ:STAA) and maintained a $77 price target.
June 08, 2023 | 3:56 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Canaccord Genuity analyst reiterates Buy rating on Staar Surgical (NASDAQ:STAA) and maintains a $77 price target.
The Buy rating and maintained price target by Canaccord Genuity analyst William Plovanic indicates a positive outlook for Staar Surgical's stock. This news is likely to have a positive impact on the stock price in the short term as it reaffirms the analyst's confidence in the company's potential.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100